Login to Your Account



Other News To Note


Thursday, December 6, 2012

• Vical Inc., of San Diego, said it inked a worldwide, nonexclusive license for rights to its Vaxfectin adjuvant to Cyvax Inc., a privately held vaccine firm, for use in malaria vaccines. Financial terms were not disclosed.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription